Optinose Announces Reporting Date for First Quarter 2021 Financial Results and Upcoming Healthcare Conference Presentation
April 28 2021 - 8:30AM
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on
patients treated by ear, nose and throat (ENT) and allergy
specialists, today announced the Company will report financial
results for the first quarter 2021 and corporate updates, before
market open on Wednesday, May 5, 2021.
Company to Host Conference CallMembers of the
Company’s leadership team will host a conference call to discuss
financial results and corporate updates. The call is scheduled to
start at 8:00 a.m. Eastern Time on Wednesday, May 5, 2021.
To participate on the conference call, please
dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from outside
the U.S. In addition, following the completion of the call, a
telephone replay will be accessible until Wednesday, May 12, 2021
by dialing (855) 859-2056 from the U.S. or +1 (404) 537-3406 from
outside the U.S. and entering conference ID #5283136. A
simultaneous webcast of the call and presentation can be accessed
by visiting the Investors section of Optinose’s website at
www.optinose.com. In addition, a replay of the webcast will be
available on the Company website for 60 days following the
event.
RBC Capital Markets Global Healthcare
Conference In addition, the Company announced that Chief
Executive Officer Peter Miller will present a company overview and
business update at the RBC Capital Markets Global Healthcare
Conference on Tuesday, May 18, 2021, at 5:25 p.m. Eastern Time.
To listen to a webcast of the presentation live,
please visit the Investors page of the Optinose website. A replay
of the webcast will be available for 30 days following the
conclusion of the event.
About OptinoseOptinose is a global specialty
pharmaceutical company focused on serving the needs of patients
cared for by ear, nose and throat (ENT) and allergy specialists. To
learn more, please visit www.optinose.com or follow us on
Twitter and LinkedIn.
Optinose Investor ContactJonathan
Neelyjonathan.neely@optinose.com 267.521.0531
OptiNose (NASDAQ:OPTN)
Historical Stock Chart
From Aug 2024 to Sep 2024
OptiNose (NASDAQ:OPTN)
Historical Stock Chart
From Sep 2023 to Sep 2024